InSilicoTrials and COSBI sign for a win-win partnership
Enrico Domenici, CEO of COSBI, expressed his enthusiasm about the collaboration, stating, “The strategic partnership with InSilicoTrials represents a crucial step towards advancing personalized medicine and nutrition. By integrating our computational models into their simulation platform, we can significantly improve decision-making, reduce costs, and accelerate the regulatory processes involved in drug development.” Luca Emili, CEO of InSilicoTrials, added, “We are thrilled to join forces with COSBI, a leader in systems biology. This partnership enables us to provide our clients with an even more powerful and comprehensive in silico approach. By incorporating COSBI’s advanced computational models and simulation tools, we can significantly enhance the efficiency and effectiveness of the drug development and regulatory approval processes.” Definitively a win-win situation.
View full press release
